GC75534
GSK-3β inhibitor 14
Also known as 5-benzyl-2-methyl-2,3-dihydro-1,5-benzothiazepin-4-one
GSK-3β inhibitor 14 (Compound 6i), benzothiazepinone derivative, is a weak GSK-3β inhibitor (IC50 >100 μM)
ChemicalCAS863004-48-2MW283.39FormulaC17H17NOS
- CAS number
- 863004-48-2
- Molecular weight
- 283.39
- Formula
- C17H17NOS
- Solubility
- DMSO： 100 mg/mL (352·87 mM; Need ultrasonic)
- InChIKey
- NMFSTGNJEJROKR-UHFFFAOYSA-N
- Catalogue number
- GC75534
- Brand
- GLPBIO
Computed properties PubChem CID 20878104 · XLogP 3.4 · TPSA 45.6 Ų · H-bond donors 0
- XLogP
- 3.4
- TPSA
- 45.6 Ų
- H-bond donors
- 0
- H-bond acceptors
- 2
- Rotatable bonds
- 2
- Heavy atoms
- 20
SMILES CC1CC(=O)N(C2=CC=CC=C2S1)CC3=CC=CC=C3
Computed descriptors from PubChem (CID 20878104), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il